Oleandomycin CAS: 3922-90-5
MF: C35H61NO12
MW: 687.86
A 16-membered macrocyclic lactone.

Oleandomycin (CAS 3922-90-5)

Oleandomycin | CAS 3922-90-5 is rated 5.0 out of 5 by 1.
  • y_2020, m_8, d_10, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_391704, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getAggregateRating, 135ms
  • REVIEWS, PRODUCT
5
1
4
0
3
0
2
0
1
0
Alternate Names: Amimycin; Matromycin
Application: Oleandomycin is a 16-membered macrocyclic lactone
CAS Number: 3922-90-5
Purity: ≥95%
Molecular Weight: 687.86
Molecular Formula: C35H61NO12
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
* Refer to Certificate of Analysis for lot specific data (including water content).

Oleandomycin is a 16-membered macrocyclic lactone, initially developed as an antibiotic in vitro but has since been phased out and is now usually used in combination in vitro with other antibiotics.

Physical State :
Solid
Derived From :
Streptomyces sp.
Solubility :
Soluble in ethanol, methanol, DMSO, DMF, and water (slightly).
Storage :
Store at -20° C
Boiling Point :
802.56° C at 760 mmHg (Predicted)
Density :
1.21 g/cm3 (Predicted)
Refractive Index :
n20D 1.53 (Predicted)
For Research Use Only. Not Intended for Diagnostic or Therapeutic Use.
RTECS :
RJ9220000
PubChem CID :
72493
MDL Number :
MFCD00242812

Download SDS (MSDS)

Certificate of Analysis

Adobe Acrobat Reader is required to reliably view,
print and comment on PDF documents

Oleandomycin (CAS 3922-90-5)  Product Citations

See how others have used Oleandomycin (CAS 3922-90-5). Click on the entry to view the PubMed entry .

Citations 1 to 1 of 1 total

PMID: # 27592322  Leavey-Roback, SL.|Krasner, SW.|Suffet, IM.| et al. 2016. Chemosphere. 164: 330-338.

Citations 1 to 1 of 1 total
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getContent, 100ms
  • QUESTIONS, PRODUCT
  • bvseo-msg: The resource to the URL or file is currently unavailable.;
Rated 5 out of 5 by from Bauer Bauer, J. et al. (PubMed 22377670) investigated the impact of stereochemistry on the biological activity of novel Oleandomycin derivatives. A set of 8-methylene-, 8-methyl-, and 8-methyl-9-dihydro-oleandomycin derivatives having different combinations of stereochemistries at positions C-8 and/or C-9 were prepared in a chemoselective and stereoselective manner and tested in vitro for antibacterial activity and inhibition of IL-6 production. They found that change of stereochemistry at these positions can exert a major influence on antibacterial activity as well as IL-6 inhibition, providing novel macrolide derivatives with diminished antibacterial and potent anti-inflammatory activity. -SCBT Publication Review
Date published: 2015-07-07
  • y_2020, m_8, d_10, h_15
  • bvseo_bulk, prod_bvrr, vn_bulk_3.0.10
  • cp_1, bvpage1
  • co_hasreviews, tv_0, tr_1
  • loc_en_US, sid_391704, prod, sort_[SortEntry(order=SUBMISSION_TIME, direction=DESCENDING)]
  • clientName_scbt
  • bvseo_sdk, java_sdk, bvseo-3.2.0
  • CLOUD, getReviews, 6ms
  • REVIEWS, PRODUCT

Santa Cruz Biotechnology, Inc. is a world leader in the development of products for the biomedical research market. Call us Toll Free at 1-800-457-3801.
Copyright © 2007-2020 Santa Cruz Biotechnology, Inc. All Rights Reserved. "Santa Cruz Biotechnology", and the Santa Cruz Biotechnology, Inc. logo, "Santa Cruz Animal Health", "San Juan Ranch", "Supplement of Champions", the San Juan Ranch logo, "Ultracruz", "Chemcruz", "Immunocruz", "Exactacruz", and "EZ Touch" are registered trademarks of Santa Cruz Biotechnology, Inc.
All trademarks are the property of their respective owners.